Article info

Download PDFPDF
Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indications

Authors

  1. Correspondence to María Núñez-Núñez PharmD and MsC, Unidad de Gestión Clínica Farmacia, University Hospital San Cecilio, Granada CP 18016, Spain; mnunez.pharm{at}gmail.com
View Full Text

Citation

Núñez-Núñez M, Casas-Hidalgo I, García-Fumero R, et al
Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indications

Publication history

  • Received August 3, 2018
  • Revised October 22, 2018
  • Accepted October 30, 2018
  • First published November 26, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.